The Marcus (MCS) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
26 Feb, 2026Executive summary
Both divisions outperformed their industries in Q4, with Theatres leading box office growth and Hotels achieving record revenue and Adjusted EBITDA for fiscal 2025, driven by favorable film slates, strategic pricing, and renovated properties.
Theatres benefited from strong family and blockbuster films, while Hotels saw stable leisure demand and strong group bookings.
Strategic reinvestments and renovations, especially at Hilton Milwaukee, contributed to outperformance.
Full year fiscal 2025 consolidated revenues increased just over 3% from the prior year, with both divisions contributing to growth.
Financial highlights
Q4 consolidated revenues were $193.5 million, up 2.8% year-over-year; full year revenues were $758.5 million, up 3.1%.
Q4 operating income was $1.7 million, impacted by $5.2 million in non-cash impairment charges; full year operating income was $17.1 million, up 5.5%.
Q4 Adjusted EBITDA was $26.8 million, up 3.6%; full year Adjusted EBITDA was $99.3 million, down 3.1%.
Q4 net earnings were $6.0 million (vs. $1.0 million prior year); full year net earnings were $12.7 million (vs. $-7.8 million prior year).
Net income and EPS benefited from a $7.6 million ($0.24/share) tax credit related to the Hilton Milwaukee renovation.
Outlook and guidance
2026 capital expenditures expected to decrease significantly to $50–$55 million, boosting free cash flow.
Free cash flow will be allocated to growth investments and shareholder returns.
Positive outlook for both divisions in 2026, with low single-digit RevPAR growth expected in hotels and a strong, franchise-heavy film slate anticipated for theaters.
Group booking pace and banquet/catering revenue for Hotels running ahead of last year.
Latest events from The Marcus
- 2025 revenue reached $758.5M with strong theatre and hotel performance and robust growth outlook.MCS
Investor presentation5 Mar 2026 - Q2 revenue dropped 15%, but hotels outperformed and group bookings surged as theatres rebounded.MCS
Q2 20242 Feb 2026 - Record Q3 revenue, earnings, and industry outperformance with a strengthened capital structure.MCS
Q3 202417 Jan 2026 - Q4 revenue up 16.6% and record hotel results, with strong momentum for 2025 growth.MCS
Q4 202423 Dec 2025 - Shelf registration enables up to $150M in securities offerings and 5M-share secondary sales.MCS
Registration Filing16 Dec 2025 - Annual meeting to vote on directors, incentive plan, executive pay, and auditor ratification.MCS
Proxy Filing2 Dec 2025 - Virtual annual meeting to vote on directors, incentive plan, pay, and auditor ratification.MCS
Proxy Filing2 Dec 2025 - Q1 revenue up 7.4%, but net loss widened to $16.8M; strong outlook for films and hotels.MCS
Q1 202519 Nov 2025 - Q2 2025 revenue up 17%, profit returns, theatres lead growth, CapEx to decline post-2025.MCS
Q2 202516 Nov 2025